Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: oppenheimer f. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.
Rostaing L, Cantarovich D, Mourad G, Budde K, Rigotti P, Mariat C, Margreiter R, Capdevilla L, Lang P, Vialtel P, Ortuño-Mirete J, Charpentier B, Legendre C, Sanchez-Plumed J, Oppenheimer F, Kessler M; CARMEN Study Group. Rostaing L, et al. Among authors: oppenheimer f. Transplantation. 2005 Apr 15;79(7):807-14. doi: 10.1097/01.tp.0000154915.20524.0a. Transplantation. 2005. PMID: 15818323 Clinical Trial.
Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols.
Diekmann F, Gutiérrez-Dalmau A, López S, Cofán F, Esforzado N, Ricart MJ, Rossich E, Saval N, Torregrosa JV, Oppenheimer F, Campistol JM. Diekmann F, et al. Among authors: oppenheimer f. Nephrol Dial Transplant. 2007 Aug;22(8):2316-21. doi: 10.1093/ndt/gfm181. Epub 2007 Apr 23. Nephrol Dial Transplant. 2007. PMID: 17452413 Clinical Trial.
Sequential quadruple immunosuppression including sirolimus in extended criteria and nonheartbeating donor kidney transplantation.
Diekmann F, Campistol JM, Saval N, Gutiérrez-Dalmau A, Arellano EM, Crespo M, Rossich E, Esforzado N, Cofán F, Ricart MJ, Torregrosa JV, Oppenheimer F. Diekmann F, et al. Among authors: oppenheimer f. Transplantation. 2007 Aug 15;84(3):429-32. doi: 10.1097/01.tp.0000269610.13590.52. Transplantation. 2007. PMID: 17700171 Clinical Trial.
Primary brain lymphomas after kidney transplantation: an under-recognized problem?
Sola-Valls N, Rodríguez C NY, Arcal C, Duran C, Oppenheimer F, Ribalta T, Lopez-Guillermo A, Campistol JM, Graus F, Diekmann F. Sola-Valls N, et al. Among authors: oppenheimer f. J Nephrol. 2014 Feb;27(1):95-102. doi: 10.1007/s40620-013-0026-z. Epub 2014 Jan 28. J Nephrol. 2014. PMID: 24469958
An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI.
Sánchez-Escuredo A, Diekmann F, Revuelta I, Esforzado N, Ricart MJ, Cofán F, Torregrosa JV, Peri L, Ruiz Á, Campistol JM, Oppenheimer F. Sánchez-Escuredo A, et al. Among authors: oppenheimer f. Transpl Int. 2016 Mar;29(3):362-8. doi: 10.1111/tri.12732. Transpl Int. 2016. PMID: 26678359 Free article.
341 results